News Manufacturing hangover drives Daiichi Sankyo into the red Long-term third-party manufacturing contracts and a slower-than-expected rollout of its cancer ADCs have driven Daiichi Sankyo into a net loss.
Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.
Market Access Collaboration is key to tackling geographical boundaries in ... Unlike most biopharmaceuticals, it is often a struggle to manufacture cell and gene therapies (CGTs) in disparate geographies.
Oncology CAR-TCR 2023 – Tim McGuire As the cell therapy world has heated up, so too has the world of cell and gene therapy contract manufacturing.
Partner Content Partner Content SpectronRx Receives U.S. Nuclear Regulatory Commission Mater... Leading Radiopharma CDMO Opens Second Location
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.